Cargando…

Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma

Multiple myeloma (MM) is a plasma-cell malignancy derived from an early precursor of the B-cell lineage characterised by bone-marrow infiltration, lytic bone lesions, and the presence of a monoclonal protein in serum and/or urine. Interferon regulatory factor 4 (IRF4) is a critical transcriptional r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butrym, Aleksandra, Łacina, Piotr, Rybka, Justyna, Chaszczewska-Markowska, Monika, Mazur, Grzegorz, Bogunia-Kubik, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334380/ https://www.ncbi.nlm.nih.gov/pubmed/28083618 http://dx.doi.org/10.1007/s00005-016-0442-6

Ejemplares similares

BSG and MCT1 Genetic Variants Influence Survival in Multiple Myeloma Patients
por: Łacina, Piotr, et al.
Publicado: (2018)

Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma
por: Dratwa, Marta, et al.
Publicado: (2023)

Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
por: Łacina, Piotr, et al.
Publicado: (2022)

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia
por: Dratwa, Marta, et al.
Publicado: (2021)

Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2018)

BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia
por: Łacina, Piotr, et al.
Publicado: (2022)

The Influence of Comorbidities on Chemokine and Cytokine Profile in Obstructive Sleep Apnea Patients: Preliminary Results
por: Chaszczewska-Markowska, Monika, et al.
Publicado: (2023)

Decreased Thrombospondin-1 and Bone Morphogenetic Protein-4 Serum Levels as Potential Indices of Advanced Stage Lung Cancer
por: Kosacka, Monika, et al.
Publicado: (2021)

Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis
por: Wielińska, Joanna, et al.
Publicado: (2021)

Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia
por: Wicherska-Pawłowska, Katarzyna, et al.
Publicado: (2022)

Genetic basis of sleep bruxism and sleep apnea—response to a medical puzzle
por: Wieckiewicz, Mieszko, et al.
Publicado: (2020)

IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
por: Iwaszko, Milena, et al.
Publicado: (2021)

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2015)

Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2016)

Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2016)

Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment
por: Wielińska, Joanna, et al.
Publicado: (2020)

Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
por: Huang, Phoebe A., et al.
Publicado: (2019)

TERT—Regulation and Roles in Cancer Formation
por: Dratwa, Marta, et al.
Publicado: (2020)

Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4
por: Zhu, Yuan Xiao, et al.
Publicado: (2019)

Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma
por: Chang, Xiubao, et al.
Publicado: (2017)

VEGF and bFGF gene polymorphisms in Polish patients with B-CLL
por: Wróbel, Tomasz, et al.
Publicado: (2013)

VEGF and bFGF Gene Polymorphisms in Patients with Non-Hodgkin's Lymphoma
por: Wróbel, Tomasz, et al.
Publicado: (2013)

Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy
por: Costacurta, Matteo, et al.
Publicado: (2021)

Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma
por: Charliński, Grzegorz, et al.
Publicado: (2021)

Genetic Variants of the TERT Gene and Telomere Length in Obstructive Sleep Apnea
por: Macek, Piotr, et al.
Publicado: (2022)

Serum NMR metabolomics to differentiate haematologic malignancies
por: Wojtowicz, Wojciech, et al.
Publicado: (2018)

Genetic Factors of Teeth Impaction: Polymorphic and Haplotype Variants of PAX9, MSX1, AXIN2, and IRF6 Genes
por: Trybek, Grzegorz, et al.
Publicado: (2023)

A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples
por: Ren, Yan, et al.
Publicado: (2016)

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study
por: Chachaj, Angelika, et al.
Publicado: (2018)

High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients
por: Butrym, Aleksandra, et al.
Publicado: (2013)

Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients
por: Kriegsmann, Katharina, et al.
Publicado: (2019)

Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma
por: Tachita, Takuto, et al.
Publicado: (2020)

Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors
por: Wielińska, Joanna, et al.
Publicado: (2021)

Case report: Unusual patient with dermatomyositis associated with SARS-CoV-2 infection
por: Niedzielska, Joanna, et al.
Publicado: (2023)

Iron Dysregulation and Frailty Syndrome
por: Zawadzki, Bartosz, et al.
Publicado: (2021)

Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia
por: Wysoczanska, Barbara, et al.
Publicado: (2019)

Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)
por: Butrym, Aleksandra, et al.
Publicado: (2015)

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2018)

Chemical Ligand Space of Cereblon
por: Boichenko, Iuliia, et al.
Publicado: (2018)

Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival
por: Xu, Qinqin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_69bjmo6vhbnpastlhe63b47pcs